In contrast, all individuals with Omicron BA.2 breakthrough infections had their mRNA boosters (3 × vaccine doses) and displayed higher levels of preexisting salivary antibodies capable of engaging FcγR early in infection as compared with the Delta breakthrough cohort (Figure 5, D and E, and Supplemental Figure 8F). Here, FCGR2A is linked to infection.